MedTrace Logo

Phase IIaTrials of GanMaoKangNing Granules

NCT02989012 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2016-12-12

No results posted yet for this study

Summary

Randomized, double-blind, double- simulation, positive drug-and-Placebo-Controlled, multicenter, phase IIa clinical trials Study about GanMaoKangNing Granules in improving the symptoms of influenza.

Conditions

  • Epidemic Influenza

Interventions

DRUG

GanMaoKangNing Granules

3 times a day, 2 bags each time.

DRUG

Analogous Oseltamivir Phosphate Capsules

2 times a day,1 capsule each time.

DRUG

Oseltamivir Phosphate Capsules

2 times a day,1 capsule each time.

DRUG

Analogous GanMaoKangNing Granules

3 times a day, 2 bags each time.

Sponsors & Collaborators

  • Dalian Zhen-Ao Bio-Tech Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2019-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02989012 on ClinicalTrials.gov